NeuroSense to Present PARADIGM Data at the American Academy of Neurology Annual Meeting April 16, 2024
Yahoo FinanceApr 12 08:30 ET
NeuroSense Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement
Yahoo FinanceApr 10 19:00 ET
NeuroSense Recaps Positive 2023 Achievements Including Statistically Significant Slowing of Disease Progression in Phase 2b ALS Trial of PrimeC and Highlights Anticipated 2024 Catalysts
Yahoo FinanceJan 9 08:45 ET
No Data
No Data